Medical Strategy is one of the leading independent healthcare investment advisers in Europe. In line with its core competence, the company focuses exclusively on managing and advising equity portfolios in the healthcare sector.

Company profile: download here

Also in 2019 Medical Strategy was awarded with the FinanzResearch AWARD. In the segment of independent asset managers in Germany, the company was rated “Outstanding”. Medical Strategy ranked 9th among the top 100 independent asset managers. For further information please click here.

At the “Funds Europe Awards” in London in November 2018, Medical Strategy received a special commendation in the category “European Specialist Investment Firm of the Year”

2019:

2018:

 

20172017
20162015
Urkunde_III_GM_2015_DrMichaelFischer_de